Kestra Advisory Services’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,532
| Closed | -$2.19K | – | 2261 |
|
|
2023
Q2 | $2.19K | Hold |
11,532
| – | – | ﹤0.01% | 2100 |
|
|
2023
Q1 | $3.92K | Hold |
11,532
| – | – | ﹤0.01% | 2043 |
|
|
2022
Q4 | $3.73K | Hold |
11,532
| – | – | ﹤0.01% | 2244 |
|
|
2022
Q3 | $5K | Hold |
11,532
| – | – | ﹤0.01% | 2096 |
|
|
2022
Q2 | $5K | Hold |
11,532
| – | – | ﹤0.01% | 2122 |
|
|
2022
Q1 | $15K | Hold |
11,532
| – | – | ﹤0.01% | 1986 |
|
|
2021
Q4 | $15K | Hold |
11,532
| – | – | ﹤0.01% | 1997 |
|
|
2021
Q3 | $24K | Hold |
11,532
| – | – | ﹤0.01% | 2101 |
|
|
2021
Q2 | $18K | Hold |
11,532
| – | – | ﹤0.01% | 1991 |
|
|
2021
Q1 | $26K | Hold |
11,532
| – | – | ﹤0.01% | 1843 |
|
|
2020
Q4 | $29K | Hold |
11,532
| – | – | ﹤0.01% | 1835 |
|
|
2020
Q3 | $28K | Buy |
+11,532
| New | +$28K | ﹤0.01% | 1396 |
|